In an in vitro experiment, the knockout of HDAC3 using CRISPR/Cas9 resulted in increased DNA damage in irradiated tumor cells, thereby reversing the resistance of rhabdomyosarcoma (RMS) to radiotherapy and exerting a radiosensitization effect [2]. Here, HDAC3 is linked to neoplasm.